ScanGrants is a public service listing of grants and other funding types to support health research, programs and scholarship.
9 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Italian Association for Cancer Research International Cancer Research Fellowships
Electronic submission deadline May 19, 2014
Paper submission (postmark) deadline May 22, 2014
The Italian Association for Cancer Research (AIRC), with partial financial support of the European Commission (7th Framework Programme: Marie Curie Actions – People – COFUND), will award a total of fourteen International Cancer Research Fellowships to highly qualified post-doctoral fellows or equivalent who wish to broaden their experience in oncologic research. This funding scheme is intended to promote the mobility of experienced researchers to and from Italy, and consists of three different types of fellowships, each for a duration of two years:
Outgoing fellowships: for researchers who have worked in Italy for more than three years out of the last four years, interested in a research experience in a scientific institution located in a different country than Italy.
Incoming Fellowships: for non-Italian scientists interested in a research experience in a scientific institution located in Italy.
Reintegration Fellowships: for Italian researchers who have worked in a country outside Italy for at least two out of the last three years, and who wish to return and work in a research center in Italy.
Eligibility criteria for applicants
At the time of the relevant deadline for submission and regardless of the type of fellowship, applicants MUST either be in possession of a doctoral degree, independently of the time taken to acquire it, or have at least four years of full-time equivalent research experience (including the period of research training) after the degree which formally allowed them to embark on a doctorate in the country in which the degree was obtained or in the country where the fellowship is taking place. Example: Italian applicants not holding a PhD must have at least four years of full research
experience after the attainment of a laurea magistralis in order to be eligible. Candidates who only have a “laurea breve/triennale” are not eligible.
In addition, the following eligibility criteria specific for each type of fellowship MUST be met:
• Applicants must have legally resided and have had their main activity (work, studies, etc.) in Italy for at least three out of the last four years prior to the relevant deadline for submission.
• The Host Institution's premises must be located in a different country than Italy.
• Applicants must not have resided or carried out their main activity (work, studies, etc.) in the country of the hosting organization for more than twelve months in the three years prior to the relevant deadline for submission.
• Applicants must be non-Italian.
• The Host Institution's premises must be located in Italy.
• Applicants must not have resided or carried out their main activity (work, studies, etc.) in Italy for more than twelve months in the three years prior to the relevant deadline for submission.
• Applicants must be Italian.
Financial support must be requested through the specific section of the online form. The financial support provided comprises:
- living and mobility allowance: this allowance is calculated multiplying a flat rate of € 50.000/year by the correction coefficient of the country of the Host Institution.
- travel allowance: up to € 1000/year, to cover a roundtrip ticket/year from the place of origin (or the home country, whichever applies) to the country of the Host Institution;
- research cost contribution: up to € 1500/year to participate to a scientific meeting.
The Living and mobility allowance will be used by the Host Institution to pay the fellow’s stipend monthly, applying the local taxes in place; in addition, in conformity with the conditions set forth in the full employment contract, the Host Institution will also deduct the mandatory employer’s contributions (e.g. pension provision): the amount remaining from the Living and mobility allowance, after the employer’s contributions have been paid and the income taxes deducted, is the fellow’s net salary. For Incoming and Reintegration fellowships: please note that the fellow cannot be taken on with a fellowship provision (“borsa di studio”), but must be hired under a regular work contract (“contratto di lavoro a tempo determinato”, or “contratto di collaborazione a progetto – co.co.pro.”). For all types of fellowships, in case the award is granted, the Legal Representative of the Host Institution and the Fellow will have to sign the “Declaration of conformity” which certifies that the fellow is hired with a full employment contract. The Living and mobility allowance will be transferred by AIRC to the Host Institution, after a specific agreement between the two parties is set up and the Declaration of conformity has been signed.
The travel allowance and the research cost contribution will be directly refunded by AIRC upon presentation of appropriate documentation.
A renewal request (first year progress report) must be submitted at the end of the first year of funding, and a detailed final report (scientific and administrative) must be prepared at the end of the funding period.
CHEST Foundation 2014 Grants and Awards Program
Each year, The CHEST Foundation offers CHEST members grants for clinical and translational research, leadership, and volunteer community service. Nearly 800 recipients worldwide have received more than $9 million to support and recognize outstanding work in chest medicine.
Application deadline: May 31
For more information, contact:
Dr. Sydney Parker, Director, Grants and Awards
Distinguished Scholar in Thrombosis Grant
GlaxoSmithKline Distinguished Scholar in Thrombosis
$150,000 awarded over 3 years
Application Deadline: May 31
The Distinguished Scholar in Thrombosis grant supports clinical educational projects to improve patient care and is intended for the investigation of issues that are not easily supported through traditional funding. The grant will support a Fellow of the American College of CHEST Physicians (FCCP) who is a recognized clinician and/or scientist with a specialty in thrombosis as evidenced by publications, presentations, and peers. The applicant must propose a thrombosis-related project that does one or more of the following:
• Investigates alternatives for treatment.
• Educates patients about options for diagnosis and treatment.
• Disseminates new knowledge about diagnosis and treatment.
• Defines new mechanisms leading to innovations and improvements to treatment.
Clinical Research Grants and Leadership Awards
The CHEST Foundation Clinical Research Grant in Lung Cancer
$100,000 awarded over 2 years
Application Deadline: May 31, 2014
This grant, establashed through a grant from Genetech, supports a clinical/translational research project that could lead to improved treatment and/or cure for lung cancer. Applicant must be a CHEST member who has completed at least 1 year of a pulmonary or critical care fellowship or a thoracic surgery residency and be within 7 years of completing training.
The CHEST Foundation Clinical Research Grant in Pulmonary Arterial Hypertension
$50,000 (July 2014 to June 2015)
This grant, established through a grant from Actelion Pharmaceuticals, US, Inc., supports a clinical/translational research project that contributes to the understanding of the pathophysiology or treatment of pulmonary arterial hypertension. Research must be completed between July 2014 and June 2015. Applicant must be a CHEST member who has completed at least 1 year of a pulmonary or critical care fellowship and be within 7 years of completing training.
The CHEST Foundation and The Pulmonary Fibrosis Foundation Clinical Research Grant in Pulmonary Fibrosis
$30,000 (July 2014 to June 2015)
This grant supports a clinical/translational research project that contributes to effective treatments or a cure for pulmonary fibrosis. Research must be completed between July 2014 and June 2015. Applicant must be a CHEST member who has completed at least 1 year of a pulmonary or critical care fellowship and be within 7 years of completing training.
Diversity Committee Young Investigator Faculty Scholar in Pulmonary, Cardiovascular, Critical Care, or Sleep Research Grant
$25,000 (July 2014 to June 2015)
This grant supports outstanding underrepresented young investigators in their careers in pulmonary, cardiovascular, critical care, or sleep research, with a focus on promoting equity and reducing disparity within a global setting. The grant supports clinical/translational research in pulmonary, cardiovascular, critical care, or sleep medicine. Research must be completed between July 2014 and June 2015.
Applicant must be a CHEST member who has completed at least 1 year of a pulmonary or critical care fellowship and be within 5 years of completing training.
The CHEST Foundation and Alpha-1 Foundation Clinical Research Grant in COPD and Alpha-1 Antitrypsin (AAT) Deficiency
This award supports research focused on COPD and AAT deficiency. While research projects primarily in usual COPD (not associated with AAT deficiency) are allowed, those with a focus on AAT deficiency are encouraged. Research must be completed between July 2014 and June 2015. Applicant must be a CHEST member who qualifies as a young investigator (ie, in an ACGME fellowship training programs and within 5 years of completion).
The CHEST Foundation and Respiratory Health Association Clinical Research Grant in Women’s Lung Health
$10,000 (July 2014 to June 2015)
This grant supports a clinical research project related to women’s lung health. Topics may include research on gender differences in lung diseases, such as COPD and lung cancer. Research must be completed between July 1, 2014 and June 30, 2015.
Applicant must be a CHEST member and hold the degree of MD, DO, MBBCh, PharmD, PhD, or the equivalent.
Community Service and Humanitarian Grants
McCaffree Community Service and Humanitarian Grants
$5,000 to $15,000
The McCaffree Community Service and Humanitarian grants are given for community-based projects supported by the service work of CHEST members worldwide. Projects must show a clear impact on the community and have the potential for long-term sustainability and replicability. Grant funds are paid to the nonprofit or nongovernmental organization where the member donates time and medical service.
Call for Applications: Alex's Lemonade Stand Foundation Bio-Therapeutics Impact Award
Application due date: June 12, 2014 (11:59 PM ET)
All requests must be submitted using ALSF’s online application.
Alex’s Lemonade Stand Foundation evolved from a young cancer patient’s front yard lemonade stand to a national foundation for childhood cancer.
The Bio-Therapeutics Impact Award accelerates the development of clinical trials for promising biologic approaches to treating childhood cancer. These approaches include, but are not limited to, immunotherapy, gene therapy and small molecules. The award, intended for investigators who are initiating clinical trials or undertaking the pre-clinical work necessary to move into the IND (investigational new drug) phase, totals the maximum of $1.5 million awarded over three years.
Call for Applications: Alex's Lemonade Stand Foundation Reach Awards
Alex's Lemonade Stand Foundation (ALSF) evolved from the front yard lemonade stand of cancer patient Alexandra “Alex” Scott (1996-2004) into a national fundraising movement to raise awareness and find cures for all childhood cancers.
Reach Awards are designed to move hypothesis-driven research toward the clinic. A successful application will identify an unmet clinical need relevant to the care of patients with pediatric cancer and describe how the work performed will allow for the translation of hypothesis-driven research to the clinic keeping broader clinical testing and implementation in view.
All Reach Award applications must be received by May 30, 2014 - 11:59 PM ET.
Maximum of $250,000 in total costs awarded over two years.
All applications must be submitted using ALSF’s online submission process.
The purpose of the Reach Award is to advance ALSF’s mission to find cures and better treatments for childhood cancers by providing support to move hypothesis-driven research into the clinic. Significant barriers exist that impede the translation of innovative and important ideas to the clinic. The Reach Award seeks to remove one of these barriers by providing support for important pre-clinical projects that are necessary to move a study from the pre-clinical arena into a clinical trial. Thus, the goal of this award is to support selected “late translational” studies needed to ultimately initiate a clinical trial. Preference will be given to those research projects which, if funded, will result in the initiation of a clinical trial within two to three years.
Primary applicants may be Assistant, Associate or Professor level investigators who demonstrate a track record of discovery, investigation and external funding. Applicants may be M.D., D.O., Ph.D, or M.D./Ph.D. Applicants must have a demonstrated track record of pediatric cancer research with experience in translational research Multiple investigator applications that bring together pairs or teams of researchers with complementary expertise are encouraged. Phase I/II Trials are not eligible for funding by this grant mechanism.
Call for Applications: Alex's Lemonade Stand Foundation ‘A’ Awards
The ‘A’ Award is a three-year grant designed for the early career scientist who wants to establish their career in pediatric oncology research. The ideal applicant has an original project that is not currently being funded. Demonstration of outstanding mentorship and a future commitment to pediatric cancer investigation are critical components of a successful application. Institutional commitment to the career of the applicant is also expected.
All applications must be received by May 23, 2014 - 11:59 PM ET.
This award totals $450,000 over three years and is open to MD, MD/PhD and PhD candidates.
‘A’ Award Program Goals To encourage the best and brightest early career researchers to build lifelong careers and become leaders in the field of pediatric cancer research. To advance research that will lead to new treatments and cures impacting children with cancer.
Highlights NEW in 2014: ALSF increased the award to $450,000 over 3 years ($150,000 per year) Recipient will have the opportunity to speak at and attend Foundation events In addition to the grant funds, the "A‟ Award provides
-- reference books to enhance personal pediatric oncology library
-- equipment to enhance lab/project work up to $10,000
-- registration fees for one educational course or event
Eligibility Criteria (Updated for 2014!) Proposals must be aligned with ALSF's mission and "A‟ Award program goals. Applicants must have an M.D., Ph.D. or dual M.D., Ph.D. (D.O., MBBS or equivalent) and must not have achieved an appointment higher than assistant professor. In addition,
-- M.D. and M.D., Ph.D. Applicants
o M.D. or M.D., Ph.D. applicants must be no more than 6 years after finishing 3-year fellowship at the time the award would start (i.e. fellowship ended in 2008 or later) and be no more than 12 years since receiving the most recent professional degree (Ph.D, M.D., D.O., MBBS or equivalent) at the time the award would start. Preference will be given to applicants no more than 12 years since receiving the first professional degree.
o M.D. candidates who did not have a 3-year fellowship must have 3 years of research experience after M.D. was awarded and be no more than 12 years since receiving the M.D. at the time the award would start.
-- Ph.D. Applicants
o Ph.D. applicants must be no more than 6 years since being awarded Ph.D. (i.e., if Ph.D. is awarded in 2008 or later, applicant is eligible for 2014 "A‟ Award). A minimum of 75% of the applicant's time during "A‟ Award must be allocated as protected time for all research activities. Applicants holding K99/R00, R01 are not eligible.
Applicants MAY have research grants from other funding sources during the "A‟ Award period, but there must be clear documentation of mechanisms to avoid scientific and budgetary overlap. Current ALSF Grant Recipients
-- Applicants currently holding an ALSF 2012 Young Investigator Award, ending June 30, 2014, are eligible to apply.
-- Applicants currently holding an ALSF 2013 Young Investigator Award or are Center of Excellence Scholars are not eligible.
-- Applicants currently holding ALSF's Innovation, Reach, Phase I/II Infrastructure or Epidemiology grants are not eligible to apply for the 2014 "A‟ Award. Prior Young Investigator applicants: If you are submitting a Young Investigator application previously reviewed but not funded by ALSF for the "A‟ Award, you must complete the resubmission section: respond to critiques, describe changes and/or new data etc. A detailed mentoring plan for career development must be clearly articulated with appropriate letters of support. Institutional commitment to the applicant's career must be addressed. Funds must be granted to nonprofit institutions or organizations operating in the United States or Canada. Researchers need not be U.S. citizens.
Resubmissions: Only one resubmission of a previously reviewed "A‟ Award or Young Investigator proposal is permitted.
Call for Applications: American Gastroenterological Association-Aptalis Research Award in Pancreatic Disease
Eligibility: Young Investigators
Duration: Two years
Deadline: June 6, 2014
Start Date: Oct. 1, 2014
This award provides $50,000 per year for two years (total $100,000) to young investigators, instructors, research associates or equivalents interested in the function and disorders of the exocrine pancreas. Research topics suitable for funding under this grant include but are not limited to: pancreatitis, pancreatic cancer, pancreatic insufficiency, the gut microbiome-pancreas relationship, pancreatic disease epidemiology or genetics (excluding diabetes), and pancreatic disease biomarkers.
The overall objective of this career development award is to encourage and support research into exocrine pancreatic disorders by helping to sustain the careers of young investigators with an interest in pancreatic disease.
• Candidates for this award must hold an MD, PhD or equivalent degree (e.g., MB, ChB, MBBS, DO) and a full-time faculty position at a North American institution by June 1, 2014.
• AGA membership is required at the time of application submission. Please visit the membership page or call 301-654-2055, extension 651, for membership information.
• The award is intended to support young faculty (not fellows) who have demonstrated exceptional promise and have some record of accomplishment in research. Candidates should be in the beginning years of their careers; therefore, established investigators are not appropriate candidates.
• MD applicants: no more than seven years shall have elapsed following the completion of clinical training (GI fellowship or its equivalent) and the start date of this award.
• PhD applicants: no more than seven years shall have elapsed following the awarding of a PhD and the start date of this award.
• Women and underrepresented minority applicants are strongly encouraged to apply; these applications in particular will receive the review committee’s full consideration.
• An appropriately documented parental leave of absence will not be counted toward the above noted seven-year eligibility criteria. Exceptional circumstances may also be considered.
• All submissions must be relevant to diagnosing, treating or researching the functions or diseases of the exocrine pancreas.
• At the time of application submission, candidates may not hold or have held an NIH R01, R29, R21, K08, K23, Veterans Affairs Career Development Award or any award with similar objectives from non-federal sources (such as the American Liver Foundation, Burroughs Wellcome Fund, Crohn’s and Colitis Foundation of America, Robert Wood Johnson Foundation, etc.). Candidates with an active K12 may apply.
• The intent of this award is to foster the scientific independence of junior investigators. It is understood that there may be some overlap with work funded by the mentor, but the goal of this grant is to enable the junior investigator to develop their own research program. It also must be clearly stated that the work submitted by the applicant is primarily that of the applicant, and any work or data from the senior mentor’s laboratory clearly defined.
• Resources allocated through this award are intended to support the career development of the applicant. Accordingly, requests for salary, fringe benefits or other support for the mentor are not allowed. Indirect costs are not allowed. Upon notification of receipt of this award, the recipient must provide institutional approval from the appropriate committee for use of human subjects or animals. If approval is not necessary, the recipient must provide an explanation. Evidence for developing independence in research initiatives should be provided.
• Candidates are required to have a sponsor and preceptor for the award; however, one individual may serve in the capacity of both positions. A sponsor is an individual who takes responsibility for the quality assessment of the proposed research project, the quality of the research environment within which the project will be undertaken, and the experience and expertise of the principal investigator and other key researchers involved. A preceptor will supervise the principal investigator’s research activities and will serve as a mentor.
• Annually, a one-page plain language progress report, a scientific progress report, a financial statement, a list of publications based on the research and a letter of certification from the division chief or department chair, must be submitted by the award recipient by Nov. 30. Second year funding is contingent upon submission of this documentation. All publications, presentations and abstracts arising from work funded by this program must acknowledge support of the AGA-Aptalis Research Award in Pancreatic Disease.
There must be a strong commitment from the candidate’s institution to support the required protected time for research and adequate laboratory space and/or other supporting facilities. These commitments must be outlined in a letter from the candidate’s division chief or department chair. The letter must certify that the award is being used to provide protected time, in accord with the terms of the award. In addition, it is expected that the sponsor will outline specific plans for the future development of the candidate’s research career. The institution must commit to ensuring timely and accurate reporting of the awardee’s current and future research activities at the institution; this is to include an annual report of the funding status, grants submitted and pending, and all publications.
The recipient will be selected based on the following criteria: significance, investigator, innovation, approach, environment, relevance to AGA’s mission and evidence of institutional commitment. The candidate should state clearly how the additional training will benefit his/her research career.
A selection committee comprised of members of the AGA Research Awards Panel will review the proposals and select the award recipients. Funding will commence October 2014.
The application deadline is June 6, 2014. The completed application, letters of support or commitment and other documents, as applicable, must be combined into and submitted as one PDF document. The document must be titled by the applicant’s last name and first initial only. Hard copies are not accepted. Please email the application document to email@example.com. Direct all questions to the research awards manager via telephone at 301-222-4012 or email at firstname.lastname@example.org.
Funding for this award is provided by Aptalis Pharma US, Inc.
Lung Cancer Research Foundation Grant Program
Deadline: Friday, June 16, 2014
The Lung Cancer Research Foundation's grant program provides critical seed support for cutting-edge scientific research on all cancers of the lung. We believe this type of support can build proof of concept for researchers to apply for additional grant funding from universities and public sources.
LCRF GRANTS ARE AWARDED FOR LUNG CANCER PROJECTS FOCUSED ON:
• Basic Science
• Translational Research
• Clinical Research
• Supportive Care
• Quality of Care/Outcomes
LCRF PROVIDES FUNDS TO U.S. AND INTERNATIONAL INVESTIGATORS FROM NOT FOR PROFIT INSTITUTIONS:
• Graduate students
• Post-doctoral researchers
• Medical students
• Nurse researchers
North American Neuroendocrine Tumor Society Clinical Investigator Scholarship
Deadline for submission of the application is June 30, 2014 (11:59 pm PDT).
The purpose of the NANETS Clinical Investigator Scholarship is to encourage clinicians at the end of their fellowship or beginning of their faculty appointment to pursue a clinical career focused on neuroendocrine tumors.
Award Term: The NANETS Clinical Investigator Scholarship will provide $50,000 per year for one year. Award funds will be directed to the sponsoring institution. At the conclusion of the award period, the recipient must provide NANETS with a written progress report of the project performed during the award period and a budget reconciliation.
• Candidates must have a MD, MD/PhD, DO degree or equivalent
• Candidates must be in the first 5 years of a faculty appointment (instructor or above) in an accredited medical school or other institution in North America (must be on staff at time of award)
• Candidates must be a NANETS member
Selection Criteria: Criteria for selection will include both the clinical project itself and the potential of the individual to make future clinical contributions to the neuroendocrine tumor field. Strong emphasis will be placed on the career development plan and the applicant’s personal statements and the mentor’s development plan. The clinical proposal section should focus on a project with the potential to directly impact and improve the treatment of patients with neuroendocrine tumors. Appropriate projects would include (but are not limited to) correlative studies involving existing clinical trials, retrospective studies, a NET database, risk factors and/or any project with a clear clinical significance.
North American Neuroendocrine Tumor Society Young Investigator Award
The purpose of the NANETS Young Investigator Award is to encourage investigators at the end of their fellowship or beginning of their faculty appointment to pursue basic and/or translational research focused on neuroendocrine tumors.
Award Term: The NANETS Young Investigator Award will provide $50,000 per year for one year. Award funds will be directed to the sponsoring institution. At the conclusion of the award period, the recipient must provide NANETS with a written progress report of research performed during the award period and a budget reconciliation.
• Candidates must have a MD, MD/PhD, PhD, DO degree or equivalent
• Candidates must be in the first 5 years of a faculty appointment (instructor, research scientist or above) in an accredited medical school or other institution in North America
Selection Criteria: Criteria for selection will include both the research proposal itself and the potential of the individual to make future scientific and/or clinical contributions to the neuroendocrine tumor field. Strong emphasis will be placed on the career development plan and the applicant’s personal statements, as well as the research proposal. The research proposals section should focus on research projects with the potential to directly impact and improve the treatment of patients with neuroendocrine tumors. Appropriate projects would include (but are not limited to) studies of neuroendocrine tumor epidemiology, risk factors, clinical outcomes, novel treatment strategies, and translational research projects with clear clinical significance. The research proposal can include development of a clinical trial and/or correlative studies involving existing clinical trials.